drugset / Trial / NCT00383487
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine whether, in this patient population, treatment with calcitriol and Naproxen is more effective in delaying the growth of prostate cancer than treatment with calcitriol alone as seen in historical controls.
Timeline
- Start
- 2005-03
- Primary completion
- 2007-07
- Completion
- 2007-07
Outcome
Outcome not reported
Stopped: “Extreme toxicity”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcitriol | Small molecule | 0.5 ug/kg | — |
| Subject | naproxcinod | Other / unclassified | 400 mg | Oral |